LLY

Eli Lilly and Company · Healthcare · Drug Manufacturers - General
$922.50
-7.05 (-0.76%)
Mkt Cap: 871.60B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield0.9%
Dividend YieldN/A
Market Cap871.60B
Volume1.85M
Recent News
LLY Stock To $2,000?
forbes.com · 2026-04-14
Linden Lake Labs Applauds Acquisition of Portfolio Company CrossBridge Bio by Eli Lilly and Company
businesswire.com · 2026-04-14
CrossBridge Bio Enters an Agreement to be Acquired by Eli Lilly to Advance Next-Generation Dual-Payload Antibody-Drug Conjugates
businesswire.com · 2026-04-14
Eli Lilly and Company $LLY Stock Position Raised by Apollon Wealth Management LLC
defenseworld.net · 2026-04-14
Eli Lilly Advances Leukemia Drug in Late-Stage Trial
gurufocus.com · 2026-04-13
Lilly's Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL
prnewswire.com · 2026-04-13

Unlock the Full Deep Scan

9 AI agents analyze LLY across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →